Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

被引:0
作者
Pierre Bigot
Tarek Fardoun
Jean Christophe Bernhard
Evanguelos Xylinas
Julien Berger
Morgan Rouprêt
Jean-Baptiste Beauval
Samuel Lagabrielle
Souhil Lebdai
Myriam Ammi
Hervé Baumert
Bernard Escudier
Nicolas Grenier
Jean-François Hétet
Jean-Alexandre Long
Philippe Paparel
Nathalie Rioux-Leclercq
Michel Soulié
Abdel-Rahmène Azzouzi
Karim Bensalah
Jean-Jacques Patard
机构
[1] Cancerology Committee of the French Association of Urology (CCAFU),Department of Urology
[2] Angers University Hospital,Department of Urology
[3] Pontchaillou University Hospital,Department of Urology
[4] Pellegrin University Hospital,Cochin Hospital, APHP
[5] Paris Descartes University,Department of Urology
[6] Limoges University Hospital,Department of Urology
[7] La Pitié Salpetrière University Hospital,Department of Urology
[8] Toulouse University Hospital,Department of Urology
[9] Saint Joseph Hospital,Department of Medical Oncology
[10] Institut Gustave Roussy,Department of Radiology
[11] Pellegrin University Hospital,Department of Urology
[12] Clinique Jules Verne,Department of Urology
[13] Grenoble University Hospital,Department of Urology
[14] Lyon Sud University Hospital,Department of Pathology
[15] Pontchaillou University Hospital,Department of Urology
[16] Bicêtre University Hospital,undefined
来源
World Journal of Urology | 2014年 / 32卷
关键词
Renal cell carcinoma; Surgical treatment; Targeted molecular therapies; Oncologic outcome; Functional outcome; Complication;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:109 / 114
页数:5
相关论文
共 143 条
[1]  
Kirkali Z(2007)A critical analysis of surgery for kidney cancer with vena cava invasion Eur Urol 52 658-662
[2]  
Van Poppel H(2012)Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus BJU Int 110 926-939
[3]  
Lawindy SM(2011)Oncological outcomes in patients undergoing radical nephrectomy and vena cava thrombectomy for renal cell carcinoma with venous extension: a single-centre experience Eur J Surg Oncol 37 422-428
[4]  
Kurian T(2006)Oncological results of renal cancer with inferior vena cava thrombosis after nephrectomy Prog Urol 16 297-302
[5]  
Kim T(2007)Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus Urology 69 1054-1058
[6]  
Mangar D(2011)New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview Oncologist 16 1-3
[7]  
Armstrong PA(2010)Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma J Clin Oncol 28 1502-1507
[8]  
Alsina AE(2009)Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma J Urol 181 518-523
[9]  
Sheffield C(2009)Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma Eur Urol 55 1477-1480
[10]  
Sexton WJ(2008)Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi Eur Urol 53 845-848